Leviathan Therapeutics
Waltham, US · Founded 2022 · Delaware corporation
Find your way into Leviathan Therapeutics
Sign up to see every warm intro you have to Leviathan Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Leviathan Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
BG
Brian GastmanNamed on SEC filing
ML
Melissa LokugamageNamed on SEC filing
LM
Lauren MifflinNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$250K disclosed across 1 round · 2022
▶$250KraisedJul 2022 · 1 investors · BiotechnologyRule 506(b)
▶$250KraisedJul 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian GastmanDirector
- Melissa LokugamageDirector
- Lauren MifflinExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $250K
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Leviathan Therapeutics raised?
- Leviathan Therapeutics has disclosed $250K raised across 1 round.
- Where is Leviathan Therapeutics headquartered?
- Leviathan Therapeutics is headquartered in Waltham, US.